Tobacco Control Has Saved Nearly 4 Millions Lives, Study Estimates

Tobacco control measures like anti-smoking campaigns and cigarette taxes have prevented nearly 4 million lung cancer deaths during the past five decades, a new American Cancer Society study estimates.

More than 3.8 million lung cancer deaths were averted due to substantial reductions in smoking, gaining a little more than 76 million years ...

New Moms Benefit From Regular Workouts

Childbirth is an overwhelming accomplishment, but new mothers would do best not to rest on their laurels following delivery, a new guideline says.

New moms should clock at least two hours a week of moderate to vigorous physical activity in the first months following birth, experts recommend.

Two to four hours of exercise per week can...

Black Americans Twice As Likely To Die During Childhood As Whites

Black babies and children are more than twice as likely to die as white kids, and that gap has grown since the 1950s, a new study says.

Black kids died at a rate 2.15 times that of white children in the 2010s, researchers reported in the Annals of Internal Medicine.

That’s up slightly from the 1950s when the death rate...

Shared Your DNA With 23andMe? Experts Say It’s Time To Delete It

If you’re one of the 15 million people who shared your DNA with 23andMe, stop whatever you're doing.

Experts say now is the time to delete your data.

The genetic testing company filed for bankruptcy March 23 and is looking to sell its assets.

California Attorney General Rob Bonta issued a "consumer alert" on March 21, acc...

Susan Monarez Named CDC Director

President Donald Trump has chosen Susan Monarez to lead the U.S. Centers for Disease Control and Prevention (CDC) permanently. She has served as acting director since January.

If approved by the Senate, Monarez would become the first person without a medical degree to head the CDC in more than 50 years.

She is an infectious disease r...

Novo Nordisk to Pay $2 Billion for New Weight Loss Drug

Novo Nordisk, a Danish pharmaceutical company, has signed a major deal worth up to $2 billion for the rights to a new obesity and diabetes drug, the company announced March 24.

The drug, called UBT251, is being developed by United Bio-Technology (Hengqin) Co., a Chinese pharmaceutical company.

Novo Nordisk will pay $200 million up fr...